Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionBLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A
Latest Disclosed Ownership64,481 shares
Latest Disclosed Value $ 7,240,571
BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A reports 114.58% increase in ownership of GILD / Gilead Sciences, Inc.

On September 26, 2025 - BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A filed a NPORT-P form disclosing ownership of 64,481 shares of Gilead Sciences, Inc. (US:GILD) valued at $7,240,571 USD as of July 31, 2025. The entity filed a previous NPORT-P on June 26, 2025 disclosing 30,050 shares of Gilead Sciences, Inc.. This represents a change in shares of 114.58% during the quarter. The current value of the position is $8,236,158 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-09-26 2025-07-31 NP Gilead Sciences EC US3755581036 64,481 34,431 114.58 7,241 126.18 0.0439
2025-06-26 2025-04-30 NP Gilead Sciences EC US3755581036 30,050 -121,023 -80.11 3,202 -76.14 0.0201
2024-12-26 2024-10-31 NP Gilead Sciences EC US3755581036 151,073 87,423 137.35 13,418 177.17 0.0802
2024-09-27 2024-07-31 NP Gilead Sciences EC US3755581036 63,650 -6,170 -8.84 4,841 6.35 0.0281
2024-06-27 2024-04-30 NP Gilead Sciences EC US3755581036 69,820 -51,450 -42.43 4,552 -52.03 0.0269
2024-03-27 2024-01-31 NP Gilead Sciences EC US3755581036 121,270 -8,011 -6.20 9,491 -6.53 0.0549
2023-12-27 2023-10-31 NP Gilead Sciences EC US3755581036 129,281 26,811 26.16 10,154 30.13 0.0622
2023-09-26 2023-07-31 NP Gilead Sciences EC US3755581036 102,470 -4,895 -4.56 7,802 -11.60 0.0426
2023-06-27 2023-04-30 NP Gilead Sciences EC US3755581036 107,365 15,059 16.31 8,826 13.91 0.0482
2023-03-29 2023-01-31 NP Gilead Sciences EC US3755581036 92,306 5,356 6.16 7,748 13.57 0.0407
2022-12-27 2022-10-31 NP Gilead Sciences EC US3755581036 86,950 24,278 38.74 6,822 82.21 0.0368
2022-09-27 2022-07-31 NP Gilead Sciences EC US3755581036 62,672 12,456 24.80 3,745 25.68 0.0181
2022-06-27 2022-04-30 NP Gilead Sciences EC US3755581036 50,216 22,619 81.96 2,980 57.20 0.0135
2022-03-29 2022-01-31 NP Gilead Sciences EC US3755581036 27,597 19,266 231.26 1,895 250.93 0.0077
2021-12-28 2021-10-31 NP Gilead Sciences EC US3755581036 8,331 1,598 23.73 541 17.65 0.0020
2021-09-28 2021-07-31 NP Gilead Sciences EC US3755581036 6,733 -6,294 -48.32 460 -44.43 0.0017
2021-06-28 2021-04-30 NP Gilead Sciences EC US3755581036 13,027 7,729 145.89 827 138.04 0.0031
2021-03-31 2021-01-31 NP Gilead Sciences EC US3755581036 5,298 -284,687 -98.17 348 -97.94 0.0014
2020-12-28 2020-10-31 NP Gilead Sciences EC US3755581036 289,985 -530,276 -64.65 16,863 -70.43 0.0753
2020-09-28 2020-07-31 NP Gilead Sciences EC US3755581036 820,261 -19,010 -2.27 57,033 -19.10 0.2525
2020-06-26 2020-04-30 NP Gilead Sciences EC US3755581036 839,271 -364,833 -30.30 70,499 -7.36 0.3373
2020-03-27 2020-01-31 NP Gilead Sciences EC US3755581036 1,204,104 -8,113 -0.67 76,099 -1.46 0.3240
2019-12-24 2019-10-31 NP Gilead Sciences EC US3755581036 1,212,217 1,212,217 77,230 0.3199
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.